SMOTE-Based Automated PCOS Prediction Using Lightweight Deep Learning Models

The reproductive age of women is particularly vulnerable to the effects of polycystic ovarian syndrome (PCOS). High levels of testosterone and other male hormones are frequent contributors to PCOS. It is believed that miscarriages and ovulation problems are majorly caused by PCOS. A recent study found that 31.3% of Asian women have been afflicted with PCOS. Healing women with life-threatening disorders associated with PCOS requires more research. In prior research, methods have involved autonomously classified PCOS using a number of different machine learning techniques. ML-based approaches involve hand-crafted feature extraction and suffer from low performance issues, which cannot be ignored for the accurate prediction and identification of PCOS.

Hence, predicting PCOS using cutting-edge deep learning methods for automated feature engineering with better performance is the prime focus of this study.

The proposed method suggests three lightweight (LSTM-based, CNN-based, and CNN-LSTM-based) deep learning models, incorporating SMOTE for dataset balancing to obtain a valid performance.

The proposed three models tend to offer an accuracy of 92.04%, 96.59%, and 94.31%, an ROC-AUC of 92.0%, 96.6%, and 94.3%, the number of parameters of 6689, 297, and 13285, and a training time of 67.27 s, 10.02 s, and 18.51 s, respectively. In addition, the DeLong test is also performed to compare AUCs to assess the statistical significance of all three models. Among all three models, the SMOTE + CNN models performs better in terms of accuracy, precision, recall, AUC, number of parameters, training time, DeLong's p-value over the other.

Moreover, a performance comparison is also carried out with other state-of-the-art PCOS detection studies and methods, which validates the better performance of the proposed model. Thus, the proposed model provides the greatest performance, which can lead to a reduction in the number of failed pregnancies and help in finding PCOS in the early stages.